Free Trial

Corebridge Financial Inc. Sells 931 Shares of Humana Inc. $HUM

Humana logo with Medical background

Key Points

  • Corebridge Financial Inc. reduced its holdings in Humana Inc. by 3.1%, now owning 29,529 shares valued at approximately $7.81 million.
  • Humana reported earnings per share of $6.27 for the last quarter, falling short of expectations, while revenue increased by 9.6% year-over-year.
  • The company announced a quarterly dividend of $0.885 per share, with a payout ratio of 27.17% and a dividend yield of 1.2%.
  • Five stocks we like better than Humana.

Corebridge Financial Inc. cut its holdings in Humana Inc. (NYSE:HUM - Free Report) by 3.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 29,529 shares of the insurance provider's stock after selling 931 shares during the quarter. Corebridge Financial Inc.'s holdings in Humana were worth $7,813,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Cary Street Partners Investment Advisory LLC raised its holdings in Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after buying an additional 46 shares during the period. Applied Finance Capital Management LLC raised its holdings in Humana by 1.7% during the 1st quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider's stock worth $779,000 after buying an additional 48 shares during the period. Achmea Investment Management B.V. raised its holdings in Humana by 0.5% during the 1st quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock worth $2,746,000 after buying an additional 49 shares during the period. Beech Hill Advisors Inc. raised its holdings in Humana by 6.1% during the 1st quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock worth $229,000 after buying an additional 50 shares during the period. Finally, Townsquare Capital LLC raised its holdings in Humana by 2.8% during the 1st quarter. Townsquare Capital LLC now owns 2,255 shares of the insurance provider's stock worth $597,000 after buying an additional 61 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts have issued reports on the company. Truist Financial cut their price objective on Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a report on Wednesday, July 16th. Barclays set a $275.00 price objective on Humana and gave the stock an "equal weight" rating in a report on Thursday, July 31st. Wall Street Zen downgraded Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Wells Fargo & Company cut their price objective on Humana from $348.00 to $344.00 and set an "overweight" rating on the stock in a report on Thursday, August 14th. Finally, Bank of America upped their target price on Humana from $285.00 to $312.00 and gave the company a "neutral" rating in a report on Tuesday. Seven research analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company. Based on data from MarketBeat, Humana has an average rating of "Hold" and a consensus price target of $285.76.

View Our Latest Analysis on HUM

Humana Stock Up 1.6%

Shares of NYSE HUM traded up $4.98 during trading hours on Tuesday, hitting $308.64. The stock had a trading volume of 1,114,392 shares, compared to its average volume of 1,700,912. The company has a market capitalization of $37.12 billion, a P/E ratio of 23.70, a P/E/G ratio of 1.79 and a beta of 0.44. The firm's 50-day moving average price is $255.81 and its two-hundred day moving average price is $254.94. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $382.72. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing the consensus estimate of $6.32 by ($0.05). The firm had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The company's quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. Analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.1%. Humana's payout ratio is presently 27.17%.

Humana Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Stories

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Should You Invest $1,000 in Humana Right Now?

Before you consider Humana, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.

While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines